Actively Recruiting
Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
Led by Sohag University · Updated on 2025-02-11
40
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to assess the safety and efficacy of surgical evacuation of spontaneous intracerebral hemorrhage.
CONDITIONS
Official Title
Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with radiological findings of intracerebral hemorrhage (ICH)
- Age between 20 and 70 years
You will not qualify if you...
- Traumatic intracerebral hemorrhage, ruptured aneurysm, arteriovenous malformation, or brain tumor
- Postoperative cranial surgery intracerebral hemorrhage
- Secondary hydrocephalus
- Liver cell failure or renal cell failure
- Bleeding disorders
- Regular use of anticoagulant or antiplatelet therapy
- Small sized intracerebral hemorrhage less than 30 ml
- Glasgow Coma Scale (GCS) less than 6 before surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag University hospitals
Sohag, Egypt
Actively Recruiting
Research Team
M
Mohamed A Ragheb, Demonstrator
CONTACT
A
Ahmed S Mohamed, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here